We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorBonaterra, Gabriel A.
dc.contributor.authorDriscoll, David F.
dc.contributor.authorSchwarzbach, Hans
dc.contributor.authorKinscherf, Ralf
dc.date2022-08-11T08:09:47.000
dc.date.accessioned2022-08-23T16:43:32Z
dc.date.available2022-08-23T16:43:32Z
dc.date.issued2017-03-15
dc.date.submitted2017-09-12
dc.identifier.citationMar Drugs. 2017 Mar 15;15(3). pii: E74. doi: 10.3390/md15030074. <a href="https://doi.org/10.3390/md15030074">Link to article on publisher's site</a>
dc.identifier.issn1660-3397 (Linking)
dc.identifier.doi10.3390/md15030074
dc.identifier.pmid28294970
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40315
dc.description.abstractBACKGROUND: Parenteral nutrition is often a mandatory therapeutic strategy for cases of septicemia. Likewise, therapeutic application of anti-oxidants, anti-inflammatory therapy, and endotoxin lowering, by removal or inactivation, might be beneficial to ameliorate the systemic inflammatory response during the acute phases of critical illness. Concerning anti-inflammatory properties in this setting, omega-3 fatty acids of marine origin have been frequently described. This study investigated the anti-inflammatory and LPS-inactivating properties of krill oil (KO)-in-water emulsion in human macrophages in vitro. MATERIALS AND METHODS: Differentiated THP-1 macrophages were activated using specific ultrapure-LPS that binds only on the toll-like receptor 4 (TLR4) in order to determine the inhibitory properties of the KO emulsion on the LPS-binding capacity, and the subsequent release of TNF-alpha. RESULTS: KO emulsion inhibited the macrophage binding of LPS to the TLR4 by 50% (at 12.5 microg/mL) and 75% (at 25 microg/mL), whereas, at 50 microg/mL, completely abolished the LPS binding. Moreover, KO (12.5 microg/mL, 25 microg/mL, or 50 microg/mL) also inhibited (30%, 40%, or 75%, respectively) the TNF-alpha release after activation with 0.01 microg/mL LPS in comparison with LPS treatment alone. CONCLUSION: KO emulsion influences the LPS-induced pro-inflammatory activation of macrophages, possibly due to inactivation of the LPS binding capacity.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28294970&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © 2017 by the authors.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectLPS
dc.subjectcytokines
dc.subjectkrill oil-in-water emulsion
dc.subjectomega-3 fatty acids
dc.subjectphospholipids
dc.subjectseptic shock
dc.subjectChemicals and Drugs
dc.subjectMedicinal Chemistry and Pharmaceutics
dc.subjectPharmacy and Pharmaceutical Sciences
dc.titleKrill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro
dc.typeJournal Article
dc.source.journaltitleMarine drugs
dc.source.volume15
dc.source.issue3
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4122&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3116
dc.identifier.contextkey10737547
refterms.dateFOA2022-08-23T16:43:32Z
html.description.abstract<p>BACKGROUND: Parenteral nutrition is often a mandatory therapeutic strategy for cases of septicemia. Likewise, therapeutic application of anti-oxidants, anti-inflammatory therapy, and endotoxin lowering, by removal or inactivation, might be beneficial to ameliorate the systemic inflammatory response during the acute phases of critical illness. Concerning anti-inflammatory properties in this setting, omega-3 fatty acids of marine origin have been frequently described. This study investigated the anti-inflammatory and LPS-inactivating properties of krill oil (KO)-in-water emulsion in human macrophages in vitro.</p> <p>MATERIALS AND METHODS: Differentiated THP-1 macrophages were activated using specific ultrapure-LPS that binds only on the toll-like receptor 4 (TLR4) in order to determine the inhibitory properties of the KO emulsion on the LPS-binding capacity, and the subsequent release of TNF-alpha.</p> <p>RESULTS: KO emulsion inhibited the macrophage binding of LPS to the TLR4 by 50% (at 12.5 microg/mL) and 75% (at 25 microg/mL), whereas, at 50 microg/mL, completely abolished the LPS binding. Moreover, KO (12.5 microg/mL, 25 microg/mL, or 50 microg/mL) also inhibited (30%, 40%, or 75%, respectively) the TNF-alpha release after activation with 0.01 microg/mL LPS in comparison with LPS treatment alone.</p> <p>CONCLUSION: KO emulsion influences the LPS-induced pro-inflammatory activation of macrophages, possibly due to inactivation of the LPS binding capacity.</p>
dc.identifier.submissionpathoapubs/3116
dc.contributor.departmentDepartment of Medicine, Division of Gastroenterology
dc.source.pages74


Files in this item

Thumbnail
Name:
marinedrugs_15_00074.pdf
Size:
1.406Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © 2017 by the authors.
Except where otherwise noted, this item's license is described as Copyright © 2017 by the authors.